Bill Hearl, Ph.D., Immunomic Therapeutics (EP.54)

By BioHealth Innovation, Inc. (BHI)

Immunomic Therapeutics Founder and CEO Bill Hearl, Ph.D. returns to BioTalk with Rich Bendis to discuss their recent successes in funding, research, and their growth in the BioHealth Capital Region

Listen to Bill Hearl, Ph.D., Immunomic Therapeutics (EP.54) now.

Listen to Bill Hearl, Ph.D., Immunomic Therapeutics (EP.54) in full in the Spotify app